Literature DB >> 7722350

Left and right heart Doppler stress echo in congestive heart failure.

T Bartel1, S Müller, A C Borges, G Baumann.   

Abstract

Doppler echocardiographic assessment of the left and right ventricular function at rest, during and 6 minutes after submaximal exercise was performed in 60 patients with a mean age of 43 +/- 11 years suffering from heart failure classified stage I-III according to the NYHA-criteria and 10 volunteers with a mean age of 36 +/- 9 years who served as a control group. At mitral (m) and tricuspid (t) valve early diastolic peak-flow velocity (VEm, VEt), atrial peak-flow velocity (VAm, VAt), speed-time integrals (Em, Et, Am, At) and the ratios (VE/VAm, VE/VAt, E/Am, E/At) were determined. The left ventricular end-diastolic diameter (LVEDD) and the right ventricular outflow tract (RVOT) were measured in addition. The left ventricular ejection fraction (LVEF) was decreased to < 36% in 9 patients (group 1). In 51 individuals LVEF was found to be > 35% but < 50% or LVEF was shown to be > 50% but VE/VAm-ratio was found to be < 1 (group 2). Out of all the determined parameters, VE/VAt, VEt and VAm during exercise were found to be the most sensitive parameters for the detection of early to advanced grade left heart failure.

Entities:  

Mesh:

Year:  1994        PMID: 7722350     DOI: 10.1007/bf01137720

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  30 in total

1.  Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: a new method of stress echocardiography.

Authors:  H Lambertz; A Kreis; H Trümper; P Hanrath
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

2.  Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty.

Authors:  E Picano; S Pirelli; M Marzilli; F Faletra; F Lattanzi; L Campolo; D Massa; A Alberti; E Gara; A Distante
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

3.  Assessment of left ventricular relaxation by Doppler echocardiography. Comparison of isovolumic relaxation time and transmitral flow velocities with time constant of isovolumic relaxation.

Authors:  Y Myreng; O A Smiseth
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

4.  Left ventricular diastolic function: comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with and without coronary artery disease.

Authors:  M F Stoddard; A C Pearson; M J Kern; J Ratcliff; D G Mrosek; A J Labovitz
Journal:  J Am Coll Cardiol       Date:  1989-02       Impact factor: 24.094

5.  Prognostic importance of dipyridamole-echocardiography test in coronary artery disease.

Authors:  E Picano; S Severi; C Michelassi; F Lattanzi; M Masini; E Orsini; A Distante; A L'Abbate
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

Review 6.  Clinical evaluation of left ventricular diastolic performance.

Authors:  W C Little; T R Downes
Journal:  Prog Cardiovasc Dis       Date:  1990 Jan-Feb       Impact factor: 8.194

Review 7.  Dipyridamole echocardiography. A new diagnostic window on coronary artery disease.

Authors:  E Picano; F Lattanzi
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  Noninvasive assessment of left and right ventricular filling in myocardial infarction with a two-dimensional Doppler echocardiographic method.

Authors:  J Fujii; Y Yazaki; H Sawada; T Aizawa; H Watanabe; K Kato
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

9.  Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools.

Authors:  A R Lucarini; E Picano; F Lattanzi; P Camici; C Marini; A Salvetti; A L'Abbate
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

10.  Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease.

Authors:  M M Pozzoli; P M Fioretti; A Salustri; A E Reijs; J R Roelandt
Journal:  Am J Cardiol       Date:  1991-02-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.